> Figure 3. Adjusted change in utilization for the pharmaceutical care and usual care groups: intention-to-treat analysis. Data adjusted for gender, age, chronic condition group (heart vs. lung), comorbid conditions, and the outcome variable at baseline.

From "Pharmaceutical Care and Health Care Utilization in an HMO" Effective Clinical Practice, March/April 2002. 49-57.

Article Text
Home

Figure 3. Adjusted change in utilization for the pharmaceutical care and usual care groups: intention-to-treat analysis. Data adjusted for gender, age, chronic condition group (heart vs. lung), comorbid conditions, and the outcome variable at baseline.

Figure 3. Adjusted change in utilization for the pharmaceutical care and usual care groups: intention-to-treat analysis. Data adjusted for gender, age, chronic condition group (heart vs. lung), comorbid conditions, and the outcome variable at baseline.

>